GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Tevogen Bio Holdings Inc (FRA:G28) » Definitions » Sale Of Investment

Tevogen Bio Holdings (FRA:G28) Sale Of Investment : €0.00 Mil (TTM As of Sep. 2024)


View and export this data going back to 2024. Start your Free Trial

What is Tevogen Bio Holdings Sale Of Investment?

Tevogen Bio Holdings's sale of investment for the three months ended in Sep. 2024 was €0.00 Mil. It means Tevogen Bio Holdings gained €0.00 Mil from selling investments. Tevogen Bio Holdings's sale of investment for the trailing twelve months (TTM) ended in Sep. 2024 was €0.00 Mil.

Compared with last quarter (€0.00 Mil in Jun. 2024 ), Tevogen Bio Holdings gained the same money from selling investments in Sep. 2024 (€0.00 Mil).


Tevogen Bio Holdings Sale Of Investment Historical Data

The historical data trend for Tevogen Bio Holdings's Sale Of Investment can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Tevogen Bio Holdings Sale Of Investment Chart

Tevogen Bio Holdings Annual Data
Trend Dec21 Dec22 Dec23
Sale Of Investment
- - -

Tevogen Bio Holdings Quarterly Data
Dec21 Jun22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Sale Of Investment Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Tevogen Bio Holdings Sale Of Investment Calculation

Sale of Investments represents cash inflow on the sale of investments in securities.

Sale Of Investment for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was €0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Tevogen Bio Holdings Sale Of Investment Related Terms

Thank you for viewing the detailed overview of Tevogen Bio Holdings's Sale Of Investment provided by GuruFocus.com. Please click on the following links to see related term pages.


Tevogen Bio Holdings Business Description

Comparable Companies
Traded in Other Exchanges
Address
15 Independence Boulevard, Warren, NJ, USA, 07059
Tevogen Bio Holdings Inc a clinical-stage specialty immunotherapy company harnessing CD8+ cytotoxic T lymphocytes ("CD8+ CTLs" or "CTLs"), to develop off-the-shelf, precision T cell therapies for the treatment of infectious diseases, cancers, and neurological disorders.

Tevogen Bio Holdings Headlines

No Headlines